GTR Home > Tests > Search results - ABCD1[gene]

Apply filters

Showing tests for all 1889 conditions

Compare labs

Your search term can be found in tests with a total of 1889 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states
More locations

GTR test search results for 215[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 56 tests for 1889 conditions in 38 labs

CAdrenoleukodystrophy

Lab: Centogene AG - the Rare Disease Company Centogene AG Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNuclearMitome Test

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (387)
Total targets (434)

CNuclear Genes involved with Mitochondrial Function (mito-exome)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Total conditions (583)
Total targets (416)

CABCD1. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CABCD1. MLPA testing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • D Deletion/duplication analysis

CNeonatal and Adult Cholestasis: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (100)
Total targets (58)

CX-linked Intellectual Disability: Gene Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (141)
Total targets (92)

CPeroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum: Sequencing Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (25)
Total targets (15)

CXLID NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (189)
Total targets (107)

CNuclear-Mito 500 NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (600)
Total targets (500)

CSpastic Paraplegia NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (44)
Total targets (24)

CPeroxisomal NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (30)
Total targets (21)

CIntellectual Disability NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (753)
Total targets (392)

CAmyotrophic Lateral Sclerosis NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (47)
Total targets (24)

CAdrenoleukodystrophy (sequence analysis of ABCD1 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 56 tests for 1889 conditions in 38 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk